Commentary

More on long-acting injectable antipsychotics


 

Psychosis and epilepsy

I just read your editorial regarding the devastating consequences of psychotic relapses (From the Editor, Current Psychiatry, May 2021, p. 9-12). I was shocked to read of the extent of the damage caused by such relapses and the positive impact of LAIs, and I thank you for opening my eyes.

I work in the spheres of psychiatry, epileptology, and whole genome sequencing, and have experienced a psychotic episode myself (in 2013, after temporal lobe resection and overdose). I now consider myself even more lucky to be out the other side! As Governor for South London and Maudsley NHS Foundation Trust (SLaM) and Trustee for Epilepsy Action, many of our patients have psychosis. Some patients with epilepsy even experience postictal psychosis. Just yesterday, we had a call at SLaM regarding patients from a secure unit, and a psychiatric nurse spoke about patients at risk to themselves and others because of their psychotic illness, and how crucial effective long-term care was.

Torie Robinson
CEO, Epilepsy Sparks

Dr. Nasrallah responds

Ms. Robinson, thank you for sharing your story. It is important to note that the neuro­biology of the psychosis that may occur with epilepsy may not be as neurodegenerative as the psychosis of schizophrenia. Many neurologic conditions can be associated with psychotic episodes, not only epilepsy. I am glad you overcame your post-temporal lobectomy psychotic episode and have had a very good outcome with high functioning.

Henry A. Nasrallah, MD
Editor-In-Chief

Disclosures
Dr. Chepke is a consultant to and speaker for Janssen Pharmaceuticals, Otsuka Pharmaceuticals, and Alkermes. The other authors report no financial relationships with any companies whose products are mentioned in their letters, or with manufacturers of competing products.

Pages

Recommended Reading

Ketamine for acute catatonia: A case report
MDedge Psychiatry
FDA okays new drug option for schizophrenia, bipolar I disorder
MDedge Psychiatry
Emotional support animals help lick symptoms of depression, anxiety in serious mental illness
MDedge Psychiatry
Once-weekly oral antipsychotic for schizophrenia on the horizon
MDedge Psychiatry
Schizophrenia meds a key contributor to cognitive impairment
MDedge Psychiatry
Cortical thinning in adolescence ‘definitively’ tied to subsequent psychosis
MDedge Psychiatry
How a community-based program for SMI pivoted during the pandemic
MDedge Psychiatry
Emerging drugs for schizophrenia targeting negative symptoms
MDedge Psychiatry
Long-acting injectable antipsychotics deserve first-line consideration
MDedge Psychiatry
Treating psychosis in pregnant women: A measured approach
MDedge Psychiatry